172 related articles for article (PubMed ID: 28364010)
1. Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
Krieger DA; Hudgins PA; Nayak GK; Baugnon KL; Corey AS; Patel MR; Beitler JJ; Saba NF; Liu Y; Aiken AH
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1193-1199. PubMed ID: 28364010
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Evaluation of NI-RADS for Detecting Postsurgical Recurrence of Oral Squamous Cell Carcinoma on Surveillance CT or MRI.
Dinkelborg P; Ro SR; Shnayien S; Schaafs LA; Koerdt S; Kreutzer K; Heiland M; Hamm B; Elsholtz FHJ
AJR Am J Roentgenol; 2021 Jul; 217(1):198-206. PubMed ID: 32876497
[No Abstract] [Full Text] [Related]
3. Neck Imaging Reporting and Data System Category 3 on Surveillance Computed Tomography: Incidence, Biopsy Rate, and Predictive Performance in Head and Neck Squamous Cell Carcinoma.
Johansson ED; Hughes RT; Meegalla NT; Porosnicu M; Patwa HS; Lack CM; Bunch PM
Laryngoscope; 2022 Sep; 132(9):1792-1797. PubMed ID: 35043989
[TBL] [Abstract][Full Text] [Related]
4. Interreader reproducibility of the Neck Imaging Reporting and Data system (NI-RADS) lexicon for the detection of residual/recurrent disease in treated head and neck squamous cell carcinoma (HNSCC).
Abdelaziz TT; Abdel Razk AAK; Ashour MMM; Abdelrahman AS
Cancer Imaging; 2020 Aug; 20(1):61. PubMed ID: 32811559
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADS.
Paul S; Gupta T; Purandare N; Joshi K; Ghosh-Laskar S; Budrukkar A; Swain M; Sinha S; Kumar A; Joshi A; Prabhash K; Nair S; Rangarajan V; Agarwal JP
Otolaryngol Head Neck Surg; 2023 Oct; 169(4):938-947. PubMed ID: 36856038
[TBL] [Abstract][Full Text] [Related]
6. Interrater Reliability of NI-RADS on Posttreatment PET/Contrast-enhanced CT Scans in Head and Neck Squamous Cell Carcinoma.
Hsu D; Rath TJ; Branstetter BF; Anzai Y; Phillips CD; Juliano AF; Mosier KM; Bazylewicz MP; Poliashenko SM; Kulzer MH; Rhyner PA; Risk B; Wiggins RH; Aiken AH
Radiol Imaging Cancer; 2021 May; 3(3):e200131. PubMed ID: 34018845
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of First Posttreatment Imaging Using Standardized Reporting in Head and Neck Cancer.
Hsu D; Chokshi FH; Hudgins PA; Kundu S; Beitler JJ; Patel MR; Aiken AH
Otolaryngol Head Neck Surg; 2019 Dec; 161(6):978-985. PubMed ID: 31331239
[TBL] [Abstract][Full Text] [Related]
8. Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
Wangaryattawanich P; Branstetter BF; Hughes M; Clump DA; Heron DE; Rath TJ
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1884-1888. PubMed ID: 30166429
[TBL] [Abstract][Full Text] [Related]
9. Performance of Neck Imaging Reporting and Data System (NI-RADS) for Diagnosis of Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Baba A; Kurokawa R; Kurokawa M; Yanagisawa T; Srinivasan A
AJNR Am J Neuroradiol; 2023 Oct; 44(10):1184-1190. PubMed ID: 37709352
[TBL] [Abstract][Full Text] [Related]
10. MRI Posttreatment Surveillance for Head and Neck Squamous Cell Carcinoma: Proposed MR NI-RADS Criteria.
Ashour MM; Darwish EAF; Fahiem RM; Abdelaziz TT
AJNR Am J Neuroradiol; 2021 Jun; 42(6):1123-1129. PubMed ID: 33707288
[TBL] [Abstract][Full Text] [Related]
11. Performance of NI-RADS on CECT Alone to Predict Recurrent Head and Neck Squamous Cell Carcinoma after Chemoradiotherapy: Added Value of RECIST 1.1.
Kumar I; Reza SO; Choudhary S; Shukla RC; Mani N; Verma A
Indian J Radiol Imaging; 2022 Jun; 32(2):151-158. PubMed ID: 35924129
[No Abstract] [Full Text] [Related]
12. NI-RADS for head and neck cancer surveillance imaging: What, why, and how.
Juliano AF; Aiken AH
Cancer Cytopathol; 2020 Mar; 128(3):166-170. PubMed ID: 31750995
[TBL] [Abstract][Full Text] [Related]
13. Impact of double reading on NI-RADS diagnostic accuracy in reporting oral squamous cell carcinoma surveillance imaging - a single-center study.
Elsholtz FHJ; Ro SR; Shnayien S; Dinkelborg P; Hamm B; Schaafs LA
Dentomaxillofac Radiol; 2022 Jan; 51(1):20210168. PubMed ID: 34233509
[TBL] [Abstract][Full Text] [Related]
14. Performance of the Neck Imaging Reporting and Data System as applied by general neuroradiologists to predict recurrence of head and neck cancers.
Lee J; Kaht D; Ali S; Johnson S; Bullen J; Karakasis C; Lamarre E; Geiger J; Koyfman S; Stock S
Head Neck; 2022 Oct; 44(10):2257-2264. PubMed ID: 35801334
[TBL] [Abstract][Full Text] [Related]
15. Detecting Residual/Recurrent Head Neck Squamous Cell Carcinomas Using PET or PET/CT: Systematic Review and Meta-analysis.
Cheung PK; Chin RY; Eslick GD
Otolaryngol Head Neck Surg; 2016 Mar; 154(3):421-32. PubMed ID: 26715675
[TBL] [Abstract][Full Text] [Related]
16. Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months?
Gore A; Baugnon K; Beitler J; Saba NF; Patel MR; Wu X; Boyce BJ; Aiken AH
AJNR Am J Neuroradiol; 2020 Jul; 41(7):1238-1244. PubMed ID: 32554418
[TBL] [Abstract][Full Text] [Related]
17. Neck Imaging Reporting and Data System: Principles and Implementation.
Hsu D; Juliano AF
Neuroimaging Clin N Am; 2020 Aug; 30(3):369-377. PubMed ID: 32600637
[TBL] [Abstract][Full Text] [Related]
18. NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
Baugnon KL
Neuroimaging Clin N Am; 2022 Feb; 32(1):1-18. PubMed ID: 34809832
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
[TBL] [Abstract][Full Text] [Related]
20. ACR Neck Imaging Reporting and Data Systems (NI-RADS): A White Paper of the ACR NI-RADS Committee.
Aiken AH; Rath TJ; Anzai Y; Branstetter BF; Hoang JK; Wiggins RH; Juliano AF; Glastonbury C; Phillips CD; Brown R; Hudgins PA
J Am Coll Radiol; 2018 Aug; 15(8):1097-1108. PubMed ID: 29983244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
